UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042283
Receipt number R000048268
Scientific Title Effects of a functional water intake on brain activity: a magnetic resonance imaging study.
Date of disclosure of the study information 2022/03/31
Last modified on 2023/07/25 14:08:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of a functional water intake on brain activity

Acronym

Effects of a functional water intake on brain activity

Scientific Title

Effects of a functional water intake on brain activity: a magnetic resonance imaging study.

Scientific Title:Acronym

Effects of a functional water intake on brain activity: a magnetic resonance imaging study.

Region

Japan


Condition

Condition

Healthy person

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the relation between a functional water intake and brain activity by the MRI images.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of brain structure and task-related brain activity after intake of the test drink or placebo drink.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of the test drink.

Interventions/Control_2

Intake of the placebo drink.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

1.Persons who are aged from 20 to 49 years and do not meet the exclusion criteria.
2.Persons who can give written informed consents.
3.Persons who are right-handed.

Key exclusion criteria

1.Persons who have previous history such as neurological disorder, nervous system disorder, cardiovascular disease, and other serious disease.
2.Persons who have previous history of nervous system disease such as unconsciousness, coma, convulsion, etc.
3.Persons with the life support equipment such as cardiac pacemaker.
4.Persons who are in treatment.
5.Persons who usually take in health foods and supplements.
6.Persons who have food allergy.
7.Persons who have vision disorder or auditory disorder.
8.Persons who are pregnant or breastfeed.
9.Persons who cannot drink soda.
10.Persons who are now participating in other clinical trials or participated in other clinical trials within a month before obtaining his/her informed consent in this trial.
11.Persons with a metallic foreign body inside or using tattoos.
12.Persons using orthodontic metal bridges.
13.Persons who cannot keep in the supine position.
14.Persons who are smoker.
15.Persons who are judged not suitable to participate in this trial by investigators.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kyosuke
Middle name
Last name Watanabe

Organization

RIKEN

Division name

Laboratory for Pathophysiological and Health Science

Zip code

650-0047

Address

6-7-1 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN

TEL

078-569-8868

Email

kyosuke.watanabe@riken.jp


Public contact

Name of contact person

1st name Kyosuke
Middle name
Last name Watanabe

Organization

RIKEN

Division name

Laboratory for Pathophysiological and Health Science

Zip code

650-0047

Address

6-7-1 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN

TEL

078-569-8868

Homepage URL


Email

kyosuke.watanabe@riken.jp


Sponsor or person

Institute

ASAHI SOFT DRINKS CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

ASAHI SOFT DRINKS CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

RIKEN

Address

2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN

Tel

078-306-3036

Email

kobe-ankan@cdb.riken.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人理化学研究所(兵庫県)


Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 07 Month 15 Day

Date of IRB

2020 Year 07 Month 31 Day

Anticipated trial start date

2020 Year 11 Month 03 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 29 Day

Last modified on

2023 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048268